Explore how PBMs negotiate drug costs, serve as middlemen between insurers and drug makers, and why they're vital yet controversial in healthcare.

As President of the Pennsylvania State Grange, I hear the same concerns from families, farmers, and small business owners across our state: prescription drug costs are too high, and the system that ...

Pharmacy middlemen working in Ohio on behalf of huge health conglomerates have long claimed they keep down drug costs. But a report released last week calls that into question. The Ohio Department of ...

In rural New Hampshire, we take pride in knowing and caring for our neighbors. At Ammonoosuc Community Health Services (ACHS), our mission is rooted in that simple truth: health care should be ...

Ohio Attorney General Dave Yost on Monday joined the vast majority of state attorneys general in demanding that Congress make a major change in the business of selling drugs. They want to prohibit ...

Imagine you’re a patient experiencing unusual symptoms. You see your primary care physician, who orders a series of lab tests, MRIs, and other diagnostic tests. You ultimately see a specialist, get ...

With federal regulators intensifying scrutiny of PBM practices and employers facing mounting ERISA and CAA-2021 fiduciary exposure, the need for a fiduciary compliant, conflict-free pharmacy benefits ...

Why is it so hard to get the medications your doctor prescribes? Why do patients and families spend countless hours fighting for standard-of-care treatments? Why do potentially life-saving drugs get ...

The National Association of Chain Drug Stores today lauded Virginia Governor Glenn Youngkin and the legislature for their efforts to enact H.B. 2610, the Save Our Pharmacies Act. The passage and ...

The House Ways and Means Committee heard testimony on hindrances to the expansion of use of biosimilars, medications close in structure and function to a patented biologic medicine. Witnesses at the ...